Grifols Share Price - GRFS

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Grifols SA GRFS NASDAQ Depository Receipt
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.135 0.62% 21.825 21.92 21.73 21.73 21.69 14:20:43
Bid Price Ask Price Spread Spread % News
21.82 21.83 0.01 0.05% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume
4,581 556,447  21.84  12,155,478 1,116,313
Last Trade Time Type Quantity Stock Price Currency
14:21:12 7  21.8201 USD

Grifols Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio
 14.93B 684.14M  675.37M 1.00 24.70 684.14M
Dividends Per Share Dividend Yield
-  0.48 2.20% 12/02/19 - -

more financials information »

News Grifols

Loading Messages....

Latest GRFS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

GRFS Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 78% of sales in 2018. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 15% of revenue following the Novartis and Hologic deals.


Your Recent History
NASDAQ
GRFS
Grifols
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.